Moderna, Inc. (MRNA)
NASDAQ
145.13
+11.81 (+8.86%)
Closed
Aug 21, 2026
Day's Range
132.42159.47
52 wk Range
22.28176.66
Financial Statements - MRNA - Moderna, Inc.
Revenue
1.92B▼ 39.9%
Net Income
-2.82B▲ 20.8%Net Margin -146.8%
EBITDA
-2.53B▲ 24.0%
Free Cash Flow
-2.07B▲ 48.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.92B | 3.19B | 6.75B | 18.87B | 17.73B | 274M |
| Cost of Goods | 868M | 1.46B | 4.69B | 5.41B | 2.61B | 8M |
| Gross Profit | 1.05B | 1.73B | 2.06B | 13.45B | 15.11B | 266M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -3.07B | -3.94B | -4.23B | 9.42B | 13.29B | -763M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2M | -63M | -86M | -16M | -29M | -6M |
| Pre Tax Income | -2.76B | -3.60B | -3.94B | 9.57B | 13.28B | -744M |
| Income Tax | 54M | -46M | 772M | 1.21B | 1.08B | 3M |
| Net Income | -2.82B | -3.56B | -4.71B | 8.36B | 12.20B | -747M |
| EPS Basic | -7.26 | -9.28 | -12.33 | 21.26 | 30.31 | -1.96 |
| EPS Diluted | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 | -1.96 |
| Basic Shares Outstanding | 389M | 384M | 382M | 394M | 403M | 381.33M |
| Diluted Shares Outstanding | 389M | 384M | 382M | 394M | 403M | 381.33M |
| Ebit | -2.75B | -3.58B | -3.90B | 9.60B | 13.29B | -763M |
| Ebitda | -2.53B | -3.33B | -3.21B | 9.97B | 13.52B | -732M |
| Net Income Continuous Operations | -2.82B | -3.56B | -4.71B | 8.36B | 12.20B | -747M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
